KIERF yields 3.45% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, KIERF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KIERF + PFE for your $10,000?
Kier Group plc primarily engages in the construction business in the United Kingdom and internationally. The company operates through three segments: Construction, Infrastructure Services, and Property. It constructs power stations, roads, bridges, railways, tunnels, and buildings for public and private sectors including schools, hospitals and prisons; and provides maintenance services for the UK road, rail, and utilities infrastructure, as well as reactive repairs. The company also offers maintenance and compliance services; housing maintenance; and facilities management services, such as cleaning, grounds maintenance, security, and pest control, as well as environmental services; and invests in and develops property schemes and sites. In addition, it provides design and business services, including project and programme management, architecture and landscape design, civil and structural engineering, building services engineering, building information modelling, cost management, strategic estates advice, building and condition surveys, ICT design and installation, business case development and feasibility, and advisory services. Kier Group plc was incorporated in 1992 and is based in Salford, the United Kingdom.
Full KIERF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.